Skip to main content

ORIGINAL RESEARCH article

Front. Neurol., 22 July 2022
Sec. Applied Neuroimaging
This article is part of the Research Topic Updates and Future Perspectives on Vessel Wall Imaging of Intracranial Aneurysms Detection, Prediction, and Classification View all 5 articles

Comparisons between cross-section and long-axis-section in the quantification of aneurysmal wall enhancement of fusiform intracranial aneurysms in identifying aneurysmal symptoms

\nFei Peng&#x;Fei Peng1Lang Liu&#x;Lang Liu2Hao NiuHao Niu1Xin FengXin Feng3Hong ZhangHong Zhang4Xiaoxin HeXiaoxin He1Jiaxiang XiaJiaxiang Xia1Boya XuBoya Xu1Xiaoyan BaiXiaoyan Bai5Zhiye LiZhiye Li5Binbin Sui*&#x;Binbin Sui6*Aihua Liu,*&#x;Aihua Liu1,2*
  • 1Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 2Department of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha, China
  • 3Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China
  • 4Operating Room, Heze Municipal Hospital, Heze, China
  • 5Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 6Tiantan Neuroimaging Center of Excellence, China National Clinical Research Center for Neurological Diseases, Beijing, China

Background: To investigate the quantification of aneurysmal wall enhancement (AWE) in fusiform intracranial aneurysms (FIAs) and to compare AWE parameters based on different sections of FIAs in identifying aneurysm symptoms.

Methods: Consecutive patients were prospectively recruited from February 2017 to November 2019. Aneurysm-related symptoms were defined as sentinel headache and oculomotor nerve palsy. All patients underwent high resolution magnetic resonance imaging (HR-MRI) protocol, including both pre and post-contrast imaging. CRstalk (signal intensity of FIAs' wall divided by pituitary infundibulum) was evaluated both in the cross-section (CRstalk−cross) and the long-axis section (CRstalk−long) of FIAs. Aneurysm characteristics include the maximal diameter of the cross-section (Dmax), the maximal length of the long-axis section (Lmax), location, type, and mural thrombus. The performance of parameters for differentiating symptomatic and asymptomatic FIAs was obtained and compared by a receiver operating characteristic (ROC) curve.

Results: Forty-three FIAs were found in 43 patients. Eighteen (41.9%) patients who presented with aneurysmal symptoms were classified in the symptomatic group. In univariate analysis, male sex (P = 0.133), age (P = 0.013), FIAs type (P = 0.167), mural thrombus (P = 0.130), Lmax (P = 0.066), CRstalk−cross (P = 0.027), and CRstalk−long (P = 0.055) tended to be associated with aneurysmal symptoms. In the cross-section model of multivariate analysis, male (P = 0.038), age (P = 0.018), and CRstalk−cross (P = 0.048) were independently associated with aneurysmal symptoms. In the long-axis section model of multivariate analysis, male (P = 0.040), age (P = 0.010), CRstalk−long (P = 0.046), and Lmax (P = 0.019) were independently associated with aneurysmal symptoms. In the combination model of multivariate analysis, male (P = 0.027), age (P = 0.011), CRstalk−cross (P = 0.030), and Lmax (P = 0.020) were independently associated with aneurysmal symptoms. CRstalk−cross has the highest accuracy in predicting aneurysmal symptoms (AUC = 0.701). The combination of CRstalk−cross and Lmax exhibited the highest performance in discriminating symptomatic from asymptomatic FIAs (AUC = 0.780).

Conclusion: Aneurysmal wall enhancement is associated with symptomatic FIAs. CRstalk−cross and Lmax were independent risk factors for aneurysmal symptoms. The combination of these two factors may improve the predictive performance of aneurysmal symptoms and may also help to stratify the instability of FIAs in future studies.

Introduction

Intracranial aneurysms (IAs) affect nearly 3%−5% of the whole population (1). IAs can be classified as saccular intracranial aneurysms (SIAs) and fusiform intracranial aneurysms (FIAs) based on aneurysm morphology. Among them, SIAs are the majority (2), while FIAs are an uncommon type, which only stand for 3%−13% of IAs (35). Compared with SIAs, FIAs depict different and numerous pathological processes (2, 6, 7). Based on pathological features, FIAs were divided into three types which include fusiform, dolichoectatic, and transitional (8).

It is reported that aneurysm growth and rupture are mediated by inflammation processes (IPs) of the aneurysmal wall (9). Recently, aneurysmal wall enhancement (AWE) in high-resolution magnetic resonance imaging (HR-MRI) has been demonstrated as the biomarker of aneurysmal wall inflammation (10, 11). Aneurysm-to-pituitary stalk (CRstalk) was reported to be the most reliable AWE quantitative parameter in SIAs (12). In addition, CRstalk was independently associated with aneurysmal symptoms in SIAs (13, 14). Similar results were also demonstrated in the study of FIAs (15). Notably, the quantification of AWE in SIAs was based on the largest section, which is located at the maximal diameter (7, 16). However, previous studies demonstrated diverse sections for AWE quantification in FIAs, which include the section with the greatest AWE, the largest aneurysmal section, and the section located at the maximal diameter (2, 7, 15). Recent studies revealed the parent vessel manifested higher enhancement in the area close to the neck of SIAs (7). Considering the pathological processes of FIAs may affect the wider involved vessel than SIAs (7), the long-axis section of FIAs which include the dilation and part of the involved artery may represent the overall influence area of FIAs, while the cross-section of the most obvious dilation may represent the degree of progression of FIAs since this section has been proved to be independently associated with aneurysm growth (16). AWE parameters based on these two sections may comprehensively reflect the aneurysmal IPs in FIAs. However, no studies have shown the CRstalk in which the section is more related to aneurysmal symptoms. As it is reported that aneurysmal symptoms (sentinel headache and oculomotor nerve palsy) may reflect the instability of IAs (14), investigating the association between CRstalk and aneurysmal symptoms may help to further understand the potential mechanisms of FIAs' instability.

This study aimed to investigate the quantification of AWE in FIAs based on two different sections and investigate the association between CRstalk in two sections of FIAs and aneurysmal symptoms to distinguish CRstalk in which section has the highest specificity in distinguishing aneurysmal symptoms.

Methods

Patient population and data collection

This prospective study was approved by the local Institutional Review Board of Beijing Tiantan Hospital, and written informed consent was obtained from each patient. The database included consecutive patients with FIAs performed by HR-MRI in Beijing Tiantan Hospital from February 2017 to November 2019. Aneurysmal symptoms were categorized by sentinel headache, oculomotor nerve palsy, and other cranial nerve symptoms (e.g. trigeminal neuralgia). Sentinel headache was defined as a severe, sudden onset headache (14). As sentinel headache and oculomotor nerve palsy may strongly indicate aneurysm instability (14), and these two symptoms were used in the investigation of the association between aneurysmal symptoms and CRstalk in two sections of FIAs. Considering the distinct pathophysiological differences between dissecting aneurysms (featured in double lumen, string sign, or intimal flap, etc.) and other FIAs (15), one experienced reader identified and excluded the dissecting aneurysms. Then, the rest FIAs were defined as three types based on Flemmings' classification: fusiform type, dolichoectatic type, and the transitional type (Figure 1) (8). Mural thrombus was defined as high T1 signal (7). We excluded those patients with poor image quality, incomplete medical records, other saccular or dissecting aneurysms, and FIAs which were related to arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), and moyamoya disease. Demographics of patients were obtained from electronic medical records.

FIGURE 1
www.frontiersin.org

Figure 1. Three types of FIAs: fusiform (A), dolichoectatic (B), and transitional (C). Time-of-flight MR images (left column), post-contrast high-resolution MR images in the long-axis of the FIAs (middle column), and post-contrast high-resolution MR images in the cross-section of the FIAs (right column) are illustrated by each IFA (star).

Imaging acquisition

All the MRI scans were performed on 3.0T MR scanners (Trio-Tim, Siemens Healthcare, Erlangen; Ingenia CX, Philips Healthcare, Best; Discovery 750, GE Healthcare, Milwaukee, WI) with a 32-channel head coil. Three-dimensional time-of-flight (3D TOF) magnetic resonance angiography (MRA) was used for the localization of the FIAs. The HR-MRI protocol included 3D T1WI (SPACE/VISTA/CUBE), 3D T2/PDWI (SPACE/VISTA/CUBE), and contrast-enhanced 3D T1WI (SPACE/VISTA/CUBE). We acquired the images in the oblique coronal plane, which covers the whole aneurysm. The voxel size was 0.7 × 0.7 × 0.7 mm3. Post-contrast T1W images were obtained 6 min after Gd injection (0.1 mmol/kg gadopentetate dimeglumine, Magnevist; Bayer Schering Pharma AG) using parameters identical to those of the pre-contrast T1W images.

HR-MRI assessment

Quantitative analysis of HR-MRI images was performed with Horos (https://horosproject.org/). The aneurysm was first identified on 3D TOF MRA images, and then the measurement of morphology was carried out on pre-contrast HR-MRI imaging. In this study, cross-section was defined as the maximal dilation in the cross-sectional plane of FIAs, which is perpendicular to the vessel centerline. The maximal diameter (Dmax) of FIAs was defined as the maximum diameter of the cross-section (15). The long-axis section was defined as the plane that covered Dmax and extended in both directions to the sites of 1.5 times the normal diameter in the parent vessel. For more precise positioning of the cross-section and the long-axis section, 3D multiplanar reconstruction (MPR) was adjusted and performed based on different projections (axial, sagittal, and coronal plane) to display the aneurysm. The maximal length (Lmax) was defined as the largest diameter of the long-axis section (17). CRstalk was defined as the value of signal intensity (SI) of FIAs' wall divided by SI of the pituitary infundibulum (7). Based on 3D MPR images, the AWE demonstrated by CRstalk was quantitatively measured on the long-axis section and the cross-section, which were manually delineated by one experienced neuroradiologist (more than 20 years in neuroimaging). CRstalk−long demonstrated the mean SI of the aneurysmal wall in the long-axis, which was calculated as ten random points of the aneurysmal wall divided by the mean SI of the stalk on the long-axis section; while on the cross-section, CRstalk−cross was also calculated using the mean SI of the aneurysmal wall divided by the mean SI of the stalk. All MR image analysis was performed by two experienced readers. Discrepancies were resolved through a consensus discussion.

Statistical analysis

All statistical analyses in this study were conducted by using SPSS (IBM, Armonk, New York, USA). Variables are expressed as mean ± SD. Statistical comparisons were performed by using the Mann–Whitney-U-test for continuous variables and χ2 test for categorical variables. Univariate analysis was performed by using a non-parametric test (Kruskal–Wallis H-test). To identify the risk factors (diameter and CRstalk of FIAs) of symptoms in different measurement methods, we classified the cross-section model, the long-axis model, and the combination model (included parameters in both cross-section model and the long-axis model). Dmax, CRstalk−cross, and other non-measurement-related parameters were first performed by univariate analysis in the cross-section model. Lmax, CRstalk−long, and other non-measurement-related parameters were first performed by univariate analysis in the long-axis model, while Dmax, CRstalk−cross, Lmax, CRstalk−long and, other non-measurement-related parameters were first performed by univariate analysis in the combination model. Variables in each model with P < 0.20 would be adopted by three models of multivariate logistic regression analysis respectively. P < 0.05 was defined as statistical significance. Discrimination, which means the ability to discriminate between symptomatic and symptomatic FIAs, was assessed by the C-statistic (areas under receiver operating characteristics curves, AUC, 0.5 indicates no ability and 1.0 indicates perfect ability). To evaluate the interobserver reliability of CRstalk, intraclass correlation coefficient was used.

Results

Thirty-one patients were excluded: 13 with poor image quality or incomplete medical records, 15 were associated with other saccular or dissecting aneurysms, and three were related to AVMs, DAVFs, and moyamoya disease. Finally, a total of 43 patients (mean age was 63.4 ± 12.7 years, male 88.9%) with 43 FIAs were included in this study (Figure 2). Among them, 30 (69.7) were fusiform type, six (14.0) were dolichoectatic type, and seven (16.3) were transitional type. There were 18 (41.9%) patients who presented with aneurysmal symptoms: 13 (30.2) with sentinel headache and five (11.6) with oculomotor nerve palsy. Characteristics of patients and FIAs were listed in Table 1.

FIGURE 2
www.frontiersin.org

Figure 2. Flowchart of patients' selection.

TABLE 1
www.frontiersin.org

Table 1. Characteristics of patients and IFAs.

In the univariate analysis, the results revealed that male sex (P = 0.133), age (P = 0.013), FIAs type (P = 0.167), mural thrombus (P = 0.130), Lmax (P = 0.066), CRstalk−cross (P = 0.027), and CRstalk−long (P = 0.055) tended to be associated with aneurysmal symptoms (Table 2). In the cross-section model of multivariate analysis, male (OR = 7.352, P = 0.038), age (OR = 0.914, P = 0.018), and CRstalk−cross (OR= 2.346, P = 0.048) were independently associated with aneurysmal symptoms. In the long-axis section model of multivariate analysis, male (OR = 7.932, P = 0.040), age (OR = 0.900, P = 0.010), CRstalk−long (OR = 2.536, P = 0.046), and Lmax (OR = 1.138, P = 0.019) were independently associated with aneurysmal symptoms. In the combination model of multivariate analysis, male (OR = 9.631, P = 0.027), age (OR = 0.900, P = 0.011), CRstalk−cross (OR = 2.995, P = 0.030), and Lmax (OR = 1.136, P = 0.020) were independently associated with aneurysmal symptoms (Table 3). Then we compared the specificity of CRstalk−cross and Lmax in aneurysmal symptoms prediction (Figure 3), and the results revealed that CRstalk−cross has higher accuracy than Lmax (AUC = 0.701 vs. AUC = 0.666) in aneurysmal symptoms prediction, while the combination of CRstalk−cross and Lmax have highest accuracy in aneurysmal symptoms prediction (AUC = 0.780).

TABLE 2
www.frontiersin.org

Table 2. The association between patients' and aneurysmal characteristics and aneurysm symptoms.

TABLE 3
www.frontiersin.org

Table 3. Three models of multivariate logistic regression analysis for risk factors associated with aneurysmal symptoms.

FIGURE 3
www.frontiersin.org

Figure 3. ROC curves of the contrast ratio of CRstalk−cross, Lmax, and the joint variable (CRstalk−cross + Lmax). The AUC value of CRstalk−cross, Lmax, and CRstalk−cross + Lmax were 0.701, 0.666, and 0.780, respectively. CRstalk−cross, aneurysm-to-pituitary stalk in the cross-axis section; Lmax, the maximal length of the long-axis section.

Reproducibility of CRstalk-cross and CRstalk-long

For the measurement of CRstalk−cross and CRstalk−long from the 43 included patients, the interobserver agreement was excellent [intraclass correlation coefficient = 0.91 (95% CI, 0.87–0.99); 0.88 (95% CI, 0.80–0.96); respectively].

Discussion

Aneurysmal wall enhancement studies have been widely investigated in SIAs (11, 13, 14, 16). Recently, AWE studies of FIAs have received much attention (2, 7, 15). In the current study, we made the first attempt to compare the accuracy of distinguishing aneurysmal symptoms between parameters that were measured in the cross-section and the long-axis section of FIAs. The results showed that there is an obvious discrepancy in the parameters of the two sections, and CRstalk−cross has the highest specificity in distinguishing aneurysmal symptoms.

Limited studies have investigated the association between AWE parameters and symptoms in FIAs (7, 15). Cao et al. (15) found that in vertebrobasilar nonsaccular aneurysms, enhancement ratio (ER), which corresponds to CRstalk in the current study, has the highest sensitivity and specificity in identifying symptoms than other AWE parameters. In their study, the measurement of AWE was based on the section of the aneurysmal wall with the highest signal intensity. In another recent study, the authors defined CRstalk > 0.60 as enhancement. The results demonstrated that headache was associated with fusiform aneurysm enhancement (7). In their study, the measurement of AWE was based on the section at the maximal diameter, while in our study, we chose both the cross-section at the maximal diameter and the long-axis section along with the superimposed dilation of the involved artery and compared CRstalk in these two sections. Among all the parameters included in this study, CRstalk in the cross-section (CRstalk−cross) has the highest performance in predicting aneurysmal symptoms. Notably, a recent study showed that AWE of the parent vessel 3 mm from the neck was higher than 5 mm from the neck (7), and since the aneurysm neck of FIAs is often not obvious due to the long dilation of the involved artery, the extent of AWE in FIAs may also be increased when closer to the most dilated areas. Similarly, the signal intensity of AWE in the long-axis section may tend to be heterogeneous and lower than in the cross-section of the most obvious dilation. Therefore, we compared the value of CRstalk between the two sections, and the mean value of CRstalk is higher in the cross-section than in the long-axis section (0.88 vs. 0.73, respectively, P < 0.001), which confirmed our hypothesis. Many previous studies have demonstrated that AWE represents aneurysmal wall IPs (10, 11), which were reported to play a key role in aneurysm growth and rupture (9, 18). As we mentioned above, CRstalk is higher in the cross-section than in the long-axis section. Thus, the extent of IPs of the aneurysmal wall in the cross-section with the maximal diameter may be higher than in the long-axis section. Therefore, we propose that for FIAs, the area with local higher AWE (cross-section with the maximal diameter) may be more inclined to grow, which needs further verification in future longitudinal studies.

In the long-axis section model, CRstalk−long and Lmax were independent predictors of aneurysm symptoms, which revealed that AWE in the long-axis section can also predict aneurysmal symptoms. Further, compared with the cross-section, which only demonstrates the section with the maximum expansion in FIAs, the long-axis section demonstrates the section along the FIAs and the parent vessel. Therefore, CRstalk in the long-axis section (CRstalk−long) tends to exhibit the Ips' burden on the entire FIA, while CRstalk−cross demonstrates that the section, which is transverse to the aneurysm trunk with the most obvious expansion, may exhibit the area with the highest Ips' burden. Still, both the two sections were performed in 2D views of FIAs, so it would be better to obtain the whole IPs burden on the FIA by using new techniques (e.g. 3D space) in future studies.

Previous studies revealed that Dmax was also related to FIAs-related symptoms (15). However, Dmax was not associated with aneurysmal symptoms in this study, and in contrast, Lmax was the independent predictor of aneurysmal symptoms (P = 0.008). Generally, symptoms were often due to the compression caused by the mass effect of bigger aneurysms (19). Lmax demonstrates the length of the longitudinal section of FIAs and the superimposed dilation of the involved artery, which may better reflect the mass effect of fusiform aneurysms on the brain tissue than Dmax. In the cross-section model, CRstalk−cross was the independent predictor of aneurysmal symptoms (P = 0.048). We also found that the performance for discriminating aneurysmal symptoms was improved when combining CRstalk−cross and Lmax (Figure 3). Therefore, in the future, CRstalk in the cross-section and the length of the long-axis section could be combined to improve the predictive performance of aneurysmal symptoms. Considering aneurysmal symptoms may indicate instability of IAs (14), those risk factors of aneurysmal symptoms (e.g. CRstalk, Lmax, and their combination) may help to stratify aneurysm rupture risk.

Other risk factors associated with symptoms include IFA types and mural thrombus (15, 20). The results of these two risk factors did not reach statistical significance. We considered it due to the limited sample size in this study.

Strengthens and limitations

This is the first study to make a quantitative evaluation of AWE in two sections for discriminating FIAs' symptoms based on HR-MRI. However, there are several inherent limitations in the current study. First, the overall sample size was small. Additionally, the limited sample size in dolichoectatic and transitional groups restricted the sub-group analysis for the three IFA types, which should be carried out in a larger cohort in future studies. Second, HR-MRI images were exported by three different 3T MRI machines (GE, Simens, and Philip) although the inherent parameters were adjusted to be consistent. Third, flow artifacts can mimic aneurysm wall enhancement in FIAs. In future studies, advanced blood suppression techniques like MSDE (motion-sensitized driven-equilibrium) (21) and DANTE (delay alternating with nutation for tailored excitation preparation module) (22) are needed to help to distinguish artifacts and improve the characterization of AWE. Fourth, the authors concentrated on two different sections which maybe not sufficiently manifest the overall AWE conditions of FIAs. More accurate methods like 3D space technology should be carried out in the future (23).

Conclusion

Aneurysm wall inflammation which can be demonstrated as enhancement is highly suggestive of inflammation, but not always. AWE on the cross-section of FIAs with the most obvious expansion may be located in higher aneurysmal IPs. CRstalk−cross and Lmax were independent risk factors for aneurysmal symptoms. The combination of these two factors may improve the predictive performance of aneurysmal symptoms and may also help to stratify the instability of FIAs.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by Institutional Review Board of Beijing Tiantan Hospital. The patients/participants provided their written informed consent to participate in this study.

Author contributions

FP made the article writing. LL made the conception and design of the study. XF, HN, HZ, XB, ZL, XH, JX, and BX made the acquisition, analysis, and interpretation of the data. BS and AL made the critical revision of the article. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the Natural Science Foundation of China (82171290 and 81771233), the Natural Science Foundation of Beijing, China (L192013, 22G10396, and 7142032), and Beijing Municipal Administration of Hospitals' Ascent Plan (DFL20190501).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Vlak MH, algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta- analysis. Lancet Neurol. (2011) 10:626–36. doi: 10.1016/S1474-4422(11)70109-0

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Liu X, Zhang Z, Zhu C, Feng J, Liu P, Kong Q, et al. Wall enhancement of intracranial saccular and fusiform aneurysms may differ in intensity and extension: a pilot study using 7-T high-resolution black-blood MRI. Eur Radiol. (2020) 30:301–7. doi: 10.1007/s00330-019-06275-9

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Anson JA, Lawton MT, Spetzler RF. Characteristics and surgical treatment of dolichoectatic and fusiform aneurysms. J Neurosurg. (1996) 84:185–93. doi: 10.3171/jns.1996.84.2.0185

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Wagner A, Prothmann S, Hedderich D, Wunderlich S, Meyer B, Lehmberg J, et al. Fusiform aneurysms of the vertebrobasilar complex: a single- center series. Acta Neurochir. (2020) 162:1343–51. doi: 10.1007/s00701-020-04304-x

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Park SH, Yim MB, Lee CY, Kim E. and Son EI. Intracranial fusiform aneurysms: it's pathogenesis, clinical characteristics and managements. J Korean Neurosurg Soc. (2008) 44:116–23. doi: 10.3340/jkns.2008.44.3.116

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Day AL Gaposchkin CG Yu CJ Rivet DJ and Dacey RG. Spontaneous fusiform middle cerebral artery aneurysms: characteristics and a proposed mechanism of formation. J Neurosurg. (2003) 99:228–40. doi: 10.3171/jns.2003.99.2.0228

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Sabotin RP, Varon A, Roa JA, Raghuram A, Ishii D, Nino M, et al. Insights into the pathogenesis of cerebral fusiform aneurysms: high-resolution MRI and computational analysis. J Neurointerv Surg. (2021) 13:1180–6. doi: 10.1136/neurintsurg-2020-017243

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Flemming KD, Wiebers DO, Brown RD, Link MJ, Huston IJ, Mcclelland RL, et al. The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis. (2005) 20:270–9. doi: 10.1159/000087710

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Turjman AS, Turjman F, Edelman ER. Role of fluid dynamics and inflammation in intracranial aneurysm formation. Circulation. (2014) 129:373–82. doi: 10.1161/CIRCULATIONAHA.113.001444

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Shimonaga K, Matsushige T, Ishii D, Sakamoto S, Hosogai M, Kawasumi T, et al. Clinicopathological insights from vessel wall imaging of unruptured intracranial aneurysms. Stroke. (2018) 49:2516–9. doi: 10.1161/STROKEAHA.118.021819

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Larsen N, von der Brelie C, Trick D, Riedel CH, Lindner T, Madjidyar J, et al. Vessel wall enhancement in unruptured intracranial aneurysms: an indicator for higher risk of rupture? High-resolution MR imaging and correlated histologic findings. AJNR Am J Neuroradiol. (2018) 39:1617–21. doi: 10.3174/ajnr.A5731

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Roa JA, Zanaty M, Osorno-Cruz C, Ishii D, Bathla G, Ortega-Gutierrez S, et al. Objective quantification of contrast enhancement of unruptured intracranial aneurysms: a high-resolution vessel wall imaging validation study. J Neurosurg. (2020) 134:862–9. doi: 10.3171/2019.12.JNS192746

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Edjlali M, Gentric JC, Régent-Rodriguez C, Trystram D, Hassen WB, Lion S, et al. Does aneurysmal wall enhancement on vessel wall MRI help to distinguish stable from unstable intracranial aneurysms? Stroke. (2014) 45:3704–6. doi: 10.1161/STROKEAHA.114.006626

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Fu Q, Wang Y, Zhang Y, Zhang Y, Guo X, Xu H, et al. Qualitative and quantitative wall enhancement on magnetic resonance imaging is associated with symptoms of unruptured intracranial aneurysms. Stroke. (2021) 52:213–22. doi: 10.1161/STROKEAHA.120.029685

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Cao L, Zhu C, Eisenmenger L, Du X, Liu J, Yang Q, et al. Wall enhancement characteristics of vertebrobasilar nonsaccular aneurysms and their relationship to symptoms. Eur J Radiol. (2020) 129:109064. doi: 10.1016/j.ejrad.2020.109064

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Wang GX, Wen L, Lei S, Ran Q, Yin JB, Gong ZL, et al. Wall enhancement ratio and partial wall enhancement on MRI associated with the rupture of intracranial aneurysms. J Neurointerv Surg. (2018) 10:566–70. doi: 10.1136/neurintsurg-2017-013308

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Moon J, Cho YD, Yoo DH, Lee JJ, Kang HS, Cho WS, et al. Growth of asymptomatic intracranial fusiform aneurysms: incidence and risk factors. Clin Neuroradiol. (2019) 29:717–23. doi: 10.1007/s00062-018-0695-z

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Frösen J, Cebral J, Robertson AM, Aoki T. Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms. Neurosurg Focus. (2019) 47:E21. doi: 10.3171/2019.5.FOCUS19234

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Mangrum Well I, Huston J, Link MJ, Wiebers DO, McClelland RL, Christianson Teresa JH, et al. Enlarging vertebrobasilar nonsaccular intracranial aneurysms: frequency, predictors, and clinical outcome of growth. J Neurosurg. (2005) 102:72–9. doi: 10.3171/jns.2005.102.1.0072

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Nasr DM, Brinjikji W, Rouchaud A, Kadirvel R, Flemming KD, Kallmes DF. Imaging characteristics of growing and ruptured vertebrobasilar non-saccular and dolichoectatic aneurysms. Stroke. (2016) 47:106–12. doi: 10.1161/STROKEAHA.115.011671

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Zhu C, Graves MJ, Yuan J, Sadat U, Gillard JH, Patterson AJ. Optimization of improved motion-sensitized driven-equilibrium (iMSDE) blood suppression for carotid artery wall imaging. J Cardiovasc Magn Reson. (2014) 16:61. doi: 10.1186/s12968-014-0061-5

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Jia S, Zhang L, Ren L, Qi Y, Ly J, Zhang N, et al. Joint intracranial and carotid vessel wall imaging in 5 minutes using compressed sensing accelerated DANTE-SPACE. Eur Radiol. (2020) 30:119–27. doi: 10.1007/s00330-019-06366-7

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Raghuram A, Varon A, Roa JA, Ishii D, Lu Y, Raghavan ML, et al. Semiautomated 3D mapping of aneurysmal wall enhancement with 7T-MRI. Sci Rep. (2021) 11:18344. doi: 10.1038/s41598-021-97727-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: fusiform aneurysm, aneurysm wall enhancement, MRI, symptom, quantification

Citation: Peng F, Liu L, Niu H, Feng X, Zhang H, He X, Xia J, Xu B, Bai X, Li Z, Sui B and Liu A (2022) Comparisons between cross-section and long-axis-section in the quantification of aneurysmal wall enhancement of fusiform intracranial aneurysms in identifying aneurysmal symptoms. Front. Neurol. 13:945526. doi: 10.3389/fneur.2022.945526

Received: 16 May 2022; Accepted: 27 June 2022;
Published: 22 July 2022.

Edited by:

Jie Lu, Capital Medical University, China

Reviewed by:

Huaizhang Shi, First Affiliated Hospital of Harbin Medical University, China
Edgar A. Samaniego, The University of Iowa, United States
Daming Wang, Peking University, China

Copyright © 2022 Peng, Liu, Niu, Feng, Zhang, He, Xia, Xu, Bai, Li, Sui and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Binbin Sui, reneesui@163.com; Aihua Liu, liuaihuadoctor@163.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.